En
Da
Fr
De
Sv
Deal History
About us
The Company
Team
Offices
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
En
Da
Fr
De
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
11 Oct 2024
Mastering Your SaaS Exit: Key Tips
Insights
23 Sep 2024
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
12 Sep 2024
Research update Biosergen: First patient treated in phase Ib study a success
Equity Research
Biosergen
29 Aug 2024
Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow
Equity Research
Nosa Plugs
23 Aug 2024
Equity Research Nosa Plugs: First impression Q2, 2024
Equity Research
Nosa Plugs
05 Aug 2024
Government Technology Sector 2024 Update
Insights
05 Jul 2024
Research update Biosergen: Taking the next clinical step
Equity Research
Biosergen
20 Jun 2024
Equity Research Nosa Plugs: New orders and distributor agreements
Equity Research
Nosa Plugs
28 May 2024
Carlsquare Consumer Conference 2024
Events
23 May 2024
Ready to Launch: Industrial Tech IPO Market 2024
Insights
17 May 2024
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
Equity Research
Nosa Plugs
13 Mar 2024
Research update Biosergen: Rights issue to fund crucial step for lead project
Equity Research
Biosergen
07 Mar 2024
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
21 Feb 2024
Equity research Nosa Plugs Q4, 2023: Record-breaking sales funding the pipeline
Equity Research
Nosa Plugs
16 Feb 2024
Equity Research Nosa Plugs: First impression Q4, 2023
Equity Research
Nosa Plugs
06 Feb 2024
Equity Research Nosa Plugs: drug delivery taking a big first step
Equity Research
Nosa Plugs
26 Jan 2024
Mrkt BUZZ H&D Wireless: Rights issue improves negotiating position
Equity Research
H&D Wireless
16 Jan 2024
Research Update Biosergen: Licensing deal with Alkem and CTA submission
Equity Research
Biosergen
08 Jan 2024
Software landscape: Growing confidence & valuation levels
Insights
21 Dec 2023
Initiation of coverage Enrad: Profiting from natural refrigerants
Equity Research
Enrad
1
2